Successfully Speaking

:
How to Prepare Your Best-Ever Presentation
Presented by Barrett Whitener, IQ Solutions

Presenter

Barrett Whitener, IQ Solutions

2

Presenting Your Work: • The Opportunities • The Challenges • The Task

3

The Hour Glass Format

Introduction

Data

Resolution

4

Take Home Message
• One Full Sentence • No Definitions • Synthesis of Conclusion Points

5

Take Home Messages Some school policies have been effective in improving dietary intake, but so far their impact on BMI is unclear. For smokers with medical illnesses, triple-combination pharmacotherapy is more effective at ending tobacco dependence than nicotine patch therapy. Muscle wasting in old age is caused in part by the increasing rigidity of blood vessels.

6

Preparation Order
1. Take Home Message 2. Main Question 3. * 4. * 5. * 6. * 7. *

Presentation Order
1. * 2. * 3. Main Question 4. * 5. * 6. Take Home Message 7. *

7

Main Question
• One Line of Inquiry • Question Form • Answered by Take Home Message

8

Main Questions How effective at reducing obesity are school policies that set nutritional standards for food sales? Which is more effective at ending tobacco dependence for medically ill smokers: pharmacotherapy or nicotine patch therapy? What subsystem activity causes muscle weakness in old age?

9

The Data Section

Main Question • Methods • Findings 1. 2. 3. 4. 5. • Conclusion Points Take Home Message

10

Selecting Helpful Images

11

Developmental Brains

GROUP (N) AVG AGE
Neonate (6) Infants (5) Teenage (8) 2 ¾ months 7 months 16 ½ years

PMI (hrs)
48.4 46.8 26.5 29.1 26.8 45.0

pH
6.25 6.54 6.48 6.40 6.52 6.26

SEX
4F/2M
2F/3M

8M 6M 7M 1F/6M

Young Adult (6) 22 ½ years Adult (7) Aged (7) 38 ½ years 76 years

Developmental Brains

GROUP (N) AVG AGE
Neonate (6) Infants (5) Teenage (8) 2 ¾ months 7 months 16 ½ years

PMI (hrs)
48.4 46.8 26.5 29.1 26.8 45.0

pH
6.25 6.54 6.48 6.40 6.52 6.26

SEX
4F/2M
2F/3M

8M 6M 7M 1F/6M

Young Adult (6) 22 ½ years Adult (7) Aged (7) 38 ½ years 76 years

Selecting Helpful Images
• Directed Focus

14

Table1 . Number of wells with elevated arsenic in USA.
State Number of wells by arsenic concentration 10–15 µg/l 16–20 µg/l 20–50 µg/l 50 µg/l+ Total wells >10 µg/l 269 5 261 530 50 1 83 81 7 38 79 20 1151 126 17 17 94 39 122 31 167 158 109 104 54 193 44 3850

Alaska Alabama Arizona California Colorado Florida Idaho Illinois Indiana Kansas Kentucky Maine Michigan Minnesota Missouri Montana North Carolina North Dakota New Hampshire New Jersey New Mexico Nevada Ohio Oklahoma Oregon Texas Utah All

98 3 114 211 23 1 35 34 5 30 73 3 425 61 8 8 53 16 52 19 89 48 64 47 31 89 20 1663

44 0 40 100 5 0 17 20 1 3 2 6 255 27 6 4 9 8 18 6 31 27 26 21 10 40 10 736

104 2 80 165 17 0 29 24 1 3 4 6 418 35 3 5 26 14 40 6 44 57 17 27 12 56 13 1208

23 0 27 54 5 0 2 3 0 2 0 2 53 3 0 0 6 1 12 0 3 26 2 9 1 8 1 243

Occurrence of Arsenic in Groundwater

Maximum Contaminant Level in US drinking water: 10 µg/L

Selecting Helpful Images
• Directed Focus

• Visualized Findings

17

CSSM-Blast Detects More True Positives Than BLAST
850 800

No. of True Positives

750

700

BLAST
650

CSSMBLAST

600

550

500 0 20 40 60 80 100 120

No. of False Positives

True vs. False Positives:
BLAST v. CSSM-BLAST
850 800

No. of True Positives

750

700

650

BLAST CSSM-BLAST

600

550

500 0 10 20 30 40 50 60 70 80 90 100

No. of False Positives

Selecting Helpful Images
• Directed Focus

• Visualized Findings • High Contrast

20

Selecting Helpful Images
• Directed Focus

• Visualized Findings • High Contrast • Title as Label

21

NIH Spending by Disease
600

500

400

Millions of Dollars

300

Lung Cancer

200

100

0 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 Year

NIH Spending by Disease
600

500

400

Millions of Dollars

300

Prostate Cancer Lung Cancer

200

100

0 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 Year

NIH Spending by Disease
600

500

400

Millions of Dollars

Breast Cancer 300 Prostate Cancer Lung Cancer

200

100

0 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 Year

Selecting Helpful Images
• Directed Focus

• Visualized Findings • High Contrast • Title as Label • “On the Same Page”

25

Myosin II function Assay in Dictyostelium Cells
Growth Rate in Suspension Culture
Cell Density (cells/ml)

DAPI Stain Nuclei

WT

WT

Mutant

107 106

Mutant
0 1 2 3 4 5 Time (days) 6

105

Development

WT

Mutant

DAPI Stain Nuclei WT Mutant

Single nucleus Small size

Multi-nuclei Big size

Selecting Helpful Images
• Directed Focus

• Visualized Findings • High Contrast • Title as Label • “On the Same Page” • Money Slide

28

Preparation Order
1. Take Home Message 2. Main Question 3. Money Slide 4. * 5. * 6. * 7. *

Presentation Order
1. * 2. * 3. Main Question 4. Money Slide 5. * 6. Take Home Message 7. *

29

Preparation Order
1. Take Home Message 2. Main Question 3. Money Slide 4. Supporting Slides 5. * 6. * 7. *

Presentation Order
1. * 2. * 3. Main Question 4. Money Slide 5. Supporting Slides 6. Take Home Message 7. *

30

Conclusions
• In children with BMI between 21.7 and 22.9 and average age of 10.49, antioxidants decreased by an average 3 points for each percentage-point increase in BMI; this result may differ in cases of severe obesity • The platelet fatty acid profile appeared to be independent of BMI percentage shifts; this relationship needs to be further examined • Stearic acid levels decreased by an average of 12 points for each percentage-point decrease in BMI; this contrasts with previous findings of 18 percent • Applying the Artificial Neural Network Map (ANN), these findings could account for the high risk of depression among obese children, as well as their lower risk for ischemia

31

Conclusions

• Antioxidants and BMI

32

Conclusions

• Antioxidants and BMI • Platelet Fatty Acids and BMI

33

Conclusions

• Antioxidants and BMI • Platelet Fatty Acids and BMI • Stearic Acid and BMI

34

Conclusions

• Antioxidants and BMI • Platelet Fatty Acids and BMI • Stearic Acid and BMI • Implications for Depression and Ischemia

35

Selecting Helpful Images
• Directed Focus

• Visualized Findings • High Contrast • Title as Label • “On the Same Page” • Money Slide • Minimal Text

36

The Introduction

Common Ground

(Background)

Main Question

37

The Introduction
Common Ground
1. What issue/challenge is the audience confronting in its work? 2. What specific aspect of the problem does your project address? 3. How are you analyzing the problem and why are you using this approach? 4. (Main Question)

Preparation Order
1. Take Home Message 2. Main Question 3. Money Slide 4. Supporting Slides 5. Common Ground 6. * 7. *

Presentation Order
1. * 2. Common Ground 3. Main Question 4. Money Slide 5. Supporting Slides 6. Take Home Message 7. *

39

The Resolution

Take Home Message

Future Directions

Exit Line

40

Preparation Order
1. Take Home Message 2. Main Question 3. Money Slide 4. Supporting Slides 5. Common Ground 6. Exit Line 7. *

Presentation Order
1. * 2. Common Ground 3. Main Question 4. Money Slide 5. Supporting Slides 6. Take Home Message 7. Exit Line

41

Preparation Order
1. Take Home Message 2. Main Question 3. Money Slide 4. Supporting Slides 5. Common Ground 6. Exit Line 7. Title

Presentation Order
1. Title 2. Common Ground 3. Main Question 4. Money Slide 5. Supporting Slides 6. Take Home Message 7. Exit Line

42

Title
• Brief (8 to 10 words) • Main-Question Orientation

43

Prenatal Risk Factors Contribute to Racial/Ethnic Differences in Childhood Obesity

44

Racial/Ethnic Differences in Childhood Obesity: Identifying Key Risk Factors

45

Title
• Brief (8 to 10 words) • Main-Question Orientation • Implication in Main Title • Detail in Sub-Title

46

Delay of Epiphyseal Fusion: An Experimental Approach for Increasing the Height of Extremely Short Children

47

Increasing the Height of Short Children: Delay of Epiphyseal Fusion

48

(Title) Common Ground

The Hour Glass Format

Introduction Main Question

Data

Money Slide Supporting Slides

Take Home Message

Resolution Exit Line
49

Your Questions

50

To Receive Feedback on Your Presentation:

humancapital@iqsolutions.com

51

Successfully Speaking:
How to Prepare Your Best-Ever Presentation
Presented by Barrett Whitener, IQ Solutions

Sign up to vote on this title
UsefulNot useful